Show Summary Details
Page of

Multi-drug resistant (MDR) bacteria and healthcare-acquired infections 

Multi-drug resistant (MDR) bacteria and healthcare-acquired infections
Multi-drug resistant (MDR) bacteria and healthcare-acquired infections

Sebastian G. B. Amyes

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 April 2021

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) and the recent appearance of vancomycin resistance.

The extended-spectrum β‎-lactamases (ESBLs) in the Enterobacteriaceae and the fall of the cephalosporins.

Carbapenem resistance in Gram-negative bacteria, a disaster currently occurring.

Clostridium difficile, a bacterium that has not developed resistance but which antibiotics have selected.

Why multi-drug resistant (MDR) bacteria spread clonally.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.